Office-based endoscopic botulinum toxin injection in laryngeal movement disorders

被引：3
作者：
Kaderbay, A. [1 ,2 ]
Righini, C. A. [1 ,2 ,3 ]
Castellanos, P. F. [4 ]
Atallah, I. [1 ,2 ,3 ,4 ]
机构：
[1] CHU Grenoble Alpes, Clin Univ ORL, BP 217, F-38043 Grenoble 09, France
[2] Univ Grenoble Alpes, CS 40700, F-38058 Grenoble 9, France
[3] Albert Bonniot Inst, INSERM 1209, CNRS, UGA,UMR 5309, F-38700 La Tronche, France
[4] Univ Alabama Birmingham, Dept Surg, Div Otolaryngol, BDB 5631720,2nd Ave South, Birmingham, AL 35294 USA
来源：
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES | 2018年 / 135卷 / 03期
关键词：
Botulinum toxin; Laryngeal movement disorders; Spasmodic dysphonia; Muscle tension dysphonia; Endoscopic injection; Office procedure; ADDUCTOR SPASMODIC DYSPHONIA; MANAGEMENT;
D O I：
10.1016/j.anorl.2018.01.007
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Introduction: Botulinum toxin injection is widely used for the treatment of laryngeal movement disorders. Electromyography-guided percutaneous injection is the technique most commonly used to perform intralaryngeal botulinum toxin injection. Objective: We describe an endoscopic approach for intralaryngeal botulinum toxin injection under local anaesthesia without using electromyography. Technique: A flexible video-endoscope with an operating channel is used. After local anaesthesia of the larynx by instillation of lidocaine, a flexible needle is inserted into the operating channel in order to inject the desired dose of botulinum toxin into the vocal and/or vestibular folds. Conclusion: Endoscopic botulinum toxin injection under local anaesthesia is a reliable technique for the treatment of laryngeal movement disorders. It can be performed by any laryngologist without the need for electromyography. It is easy to perform for the operator and comfortable for the patient. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：205 / 207
页数：3
相关论文
共 8 条
  • [1] Safety and Efficacy of Multiuse Botulinum Toxin Vials for Intralaryngeal Injection
    Barrow, Emily M.
    Rosen, Clark A.
    Hapner, Edie R.
    Smith, Sarah
    Hatcher, Jeanne L.
    Simpson, Blake
    Johns, Michael M., III
    [J]. LARYNGOSCOPE, 2015, 125 (05) : 1149 - 1154
  • [2] Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12-year experience in more than 900 patients
    Blitzer, Andrew
    Brin, Mitchell F.
    Stewart, Celia F.
    [J]. LARYNGOSCOPE, 2015, 125 (08) : 1751 - 1757
  • [3] Current Practices in the Management of Adductor Spasmodic Dysphonia
    Eskander, Antoine
    Fung, Kevin
    McBride, Simon
    Hogikyan, Norman
    [J]. JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2010, 39 (05): : 622 - 630
  • [4] Trans-nasal injection of botulinum toxin
    Hussain, A.
    Thiel, G.
    Shakeel, M.
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2009, 123 (07) : 783 - 785
  • [5] Interarytenoid Muscle Botox Injection for Treatment of Adductor Spasmodic Dysphonia With Vocal Tremor
    Kendall, Katherine A.
    Leonard, Rebecca J.
    [J]. JOURNAL OF VOICE, 2011, 25 (01) : 114 - 119
  • [6] Botulinum Toxin Treatment of False Vocal Folds in Adductor Spasmodic Dysphonia: Functional Outcomes
    Simpson, C. Blake
    Lee, Christopher T.
    Hatcher, Jeanne L.
    Michalek, Joel
    [J]. LARYNGOSCOPE, 2016, 126 (01) : 118 - 121
  • [7] TRUONG DD, 1991, LARYNGOSCOPE, V101, P630
  • [8] Abductor Paralysis After Botox Injection for Adductor Spasmodic Dysphonia
    Venkatesan, Naren N.
    Johns, Michael M.
    Hapner, Edie R.
    DelGaudio, John M.
    [J]. LARYNGOSCOPE, 2010, 120 (06) : 1177 - 1180
1